Stereotactic Radiosurgery Versus Radiofrequency Ablation for Primary Liver Cancer

Trial Details

NCT ID

NCT06766643

Phase

PHASE2

Sponsor

Tianjin Medical University Cancer Institute and Hospital

Status

RECRUITING

Cancer Type

Liver Cancer

Interventions

• Stereotactic Body Radiation Therapy (SBRT)
• Radiofrequency ablation therapy

Locations (sample)

• Tianjin, China|39.14222,117.17667

Key Eligibility Criteria

• Prior to implementing any trial-related procedures, written informed consent must be signed;
• Age ≥ 18 years and ≤ 75 years;
• Child-Pugh score ≤ 7;KPS score ≥ 70;
• The patient must be clearly diagnosed with hepatocellular carcinoma, usually confirmed through imaging (CT, MRI) or histological examination (biopsy);

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.